Annual Congress: Hematologic Malignancies

2020-hem-web-header

The NCCN 2022 Annual Congress: Hematologic Malignancies™ was held on October 14 – 15, 2022 in New York City and virtually. 

Save the dates! The NCCN 2023 Annual Congress: Hematologic Malignancies™ will take place Friday, September 22, 2023 – Saturday, September 23, 2023 at the Hilton San Francisco Union Square in San Francisco, California.

Continuing Education

Congress attendees will have the opportunity to view sessions on-demand and access materials in the Digitell platform through December 2022. 

Recorded sessions will be available in the NCCN Continuing Education Portal, education.nccn.org, later this year.

Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, the Congress featured panel discussions with world-renowned experts, interactive presentations, and challenging patient cases that highlight recent updates to the NCCN Guidelines®, new and emerging therapeutic agents, and practical management strategies for patients with hematologic malignancies. The agenda included topics designed to meet the educational needs of oncologists, hematologists, nurse practitioners, nurses, pharmacists, physician assistants, and other health care professionals who manage patients with hematologic malignancies.

This program is approved for AMA PRA Category 1 Credit and ABIM, ABPath, and ABMS MOC for physicians and is also certified for credit for nurses, pharmacists, and other oncology professionals.

This activity is supported by educational grants from:

  • AstraZeneca
  • GlaxoSmithKline
  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Kite, A Gilead Company
  • Lilly
  • Novartis
  • Seagen
  • Taiho Oncology, Inc.
This activity is supported by independent educational grants from:

  • AbbVie
  • Bristol Myers Squibb
  • Daiichi Sankyo
  • Incyte
  • Merck  & Co., Inc.

This program is supported by independent medical education grants from:

  • Jazz Pharmaceuticals
  • Pfizer Inc

This activity is supported by educational funding provided by Amgen.

This activity is supported by a medical education grant from Karyopharm Therapeutics.

 

 

Exhibition Hall

Congress attendees can continue to access Virtual Exhibits and the Patient Advocacy Pavilion in the Digitell platform through December 2022. 

View Exhibit Guide

 

For exhibitor opportunities, contact Jennifer Tredwell, Vice President, Marketing and Communications

Related Program

The NCCN 2022 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ was held on Saturday, October 15, 2022 in New York City and virtually.

Save the date! The NCCN 2023 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ will take place Friday, September 22, 2023 at the Hilton San Francisco Union Square in San Francisco, California.

Forum attendees will have access to sessions and materials in the Digitell platform through December 2022.

Recorded session will be posted on the NCCN Continuing Education Portal, education.nccn.org, later this year.